Revvity, Inc. (RVTY) Stock Grade

About Revvity, Inc.'s fundamentals

Revvity is a healthcare diagnostics and research company with an $11.0 billion market capitalization that generated 3.7% year-over-year revenue growth. The company trades at a P/E ratio of 45.5, which is elevated relative to its profitability metrics—it maintains an 8.5% net margin and generates only a 3.3% return on equity, indicating modest efficiency in converting shareholder capital into earnings. With a dividend yield of just 0.3%, Revvity returns minimal cash to shareholders and appears to be prioritizing reinvestment or balance sheet management over income distribution.